Literature DB >> 7482016

Early changes in bone mineral density above a combined anteroposterior L4-S1 lumbar spinal fusion. A clinical investigation.

G M Bogdanffy1, D D Ohnmeiss, R D Guyer.   

Abstract

STUDY
DESIGN: Fifteen patients meeting rigid study entrance criteria for undergoing a combined anteroposterior L4-S1 spinal fusion as a first time operation were included in the study. Bone mineral density changes at adjacent segments (L3 and L2) were assessed by scanning patients in the anteroposterior and lateral projections before surgery and 3 and 6 months after surgery.
OBJECTIVES: To prospectively evaluate changes in bone mineral density at adjacent segments after lumbar spinal fusion and postoperative bracing. SUMMARY OF BACKGROUND DATA: The majority of studies investigating changes in bone mineral density after spinal fusion have been performed in canines. Although such work has provided valuable insight, its application to humans is questionable because the loading mechanics are so different.
METHODS: Bone mineral density was assessed noninvasively by dual energy x-ray absorptiometry in the lateral and anteroposterior projections. Data were analyzed with special edge detection software.
RESULTS: In the lateral projection at L3, one level above the fusion, the preoperative bone mineral density was 0.91 +/- 0.24 (mean +/- standard deviation in g/cm2). This decreased significantly at 3 months to 0.82 +/- 0.24 and remained reduced at 6 months (0.80 +/- 0.21). This reflected a loss of primarily trabecular bone. In the anteroposterior projection at L2, there was a significant loss at 3- and 6-month follow-up (1.24 +/- 0.15 to 1.19 +/- 0.15 and 1.19 +/- 0.14). This may reflect changes at either or both of the anterior and posterior columns.
CONCLUSION: Significant decreases in bone mineral density were noted above fused lumbar segments. This may have been related to immobilization or altered mechanics associated with arthrodesis. Trabecular bone of the axial skeleton is most responsive to change, compared with cortical bone, because of the higher metabolic activity. This may explain the reduction of bone mineral density at L3. Changes at L2 may have been related to altered loads at the anterior or posterior columns and should be further investigated.

Entities:  

Mesh:

Year:  1995        PMID: 7482016     DOI: 10.1097/00007632-199508000-00005

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  5 in total

Review 1.  Bone health and back pain: what do we know and where should we go?

Authors:  A M Briggs; L M Straker; J D Wark
Journal:  Osteoporos Int       Date:  2008-08-21       Impact factor: 4.507

2.  Chronic low back pain is associated with reduced vertebral bone mineral measures in community-dwelling adults.

Authors:  Andrew M Briggs; Leon M Straker; Angus F Burnett; John D Wark
Journal:  BMC Musculoskelet Disord       Date:  2012-03-30       Impact factor: 2.362

3.  Degenerative spondylolisthesis is associated with low spinal bone density: a comparative study between spinal stenosis and degenerative spondylolisthesis.

Authors:  Thomas Andersen; Finn B Christensen; Bente L Langdahl; Carsten Ernst; Søren Fruensgaard; Jørgen Østergaard; Jens Langer Andersen; Sten Rasmussen; Bent Niedermann; Kristian Høy; Peter Helmig; Randi Holm; Niels Egund; Cody Bünger
Journal:  Biomed Res Int       Date:  2013-08-19       Impact factor: 3.411

4.  Spinal Endoscopy for Delayed-Onset Lumbar Radiculopathy Resulting from Foraminal Stenosis after Osteoporotic Vertebral Fracture: A Case Report of a New Surgical Strategy.

Authors:  Yuyu Ishimoto; Hiroshi Yamada; Elizabeth Curtis; Cyrus Cooper; Hiroshi Hashizume; Akihito Minamide; Yukihiro Nakagawa; Munehito Yoshida
Journal:  Case Rep Orthop       Date:  2018-10-25

5.  Impact of Instrumented Spinal Fusion on the Development of Vertebral Compression Fracture.

Authors:  Yen-Chun Chiu; Tsung-Ting Tsai; Shih-Chieh Yang; Hung-Shu Chen; Yu-Hsien Kao; Yuan-Kun Tu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.